Literature DB >> 29112565

A Randomized Control Trial of Preoperative Oral Antibiotics as Adjunct Therapy to Systemic Antibiotics for Preventing Surgical Site Infection in Clean Contaminated, Contaminated, and Dirty Type of Colorectal Surgeries.

Nadeem Anjum1, Jianan Ren, Gefei Wang, Guanwei Li, Xiuwen Wu, Hu Dong, Qin Wu, Jieshou Li.   

Abstract

BACKGROUND: Preoperative bowel preparation with or without oral antibiotics is controversial in terms of postoperative surgical site infections.
OBJECTIVE: This study aimed to evaluate the efficacy of oral antibiotics as adjunct therapy to systemic antibiotics with mechanical bowel preparation for preventing surgical site infections in clean contaminated, contaminated, and dirty colorectal procedures.
DESIGN: This was a single-center, prospective randomized study.
SETTING: This study was conducted at the General Surgery Department at Jinling Hospital, Nanjing University, China, from July 15, 2014 to January 20, 2016. PATIENTS: Patients aged ≥18 years scheduled for abdominal surgery with clean-contaminated, contaminated, and dirty wounds were selected.
INTERVENTIONS: Patients were randomly assigned to receive preoperative mechanical bowel preparation or mechanical bowel preparation with oral antibiotics. MAIN OUTCOMES: The primary outcome was the rate of surgical site infections. The secondary outcomes were extra-abdominal complications, duration of postoperative ileus, and readmission rate.
RESULTS: Ninety-five patients were allocated to each group. Eight and 26 surgical site infections (8.42% vs 27.3 %, p = 0.004) occurred in the mechanical bowel preparation with oral antibiotics and mechanical bowel preparation groups. Thirteen extra-abdominal complications were reported: 6 in the mechanical bowel preparation with oral antibiotics group and 7 in the mechanical bowel preparation group (6.3% vs 7.3%, p = 0.77). Postoperative ileus duration did not differ between groups (p = 0.23). There were 4 readmissions in the mechanical bowel preparation group and none in the mechanical bowel preparation with oral antibiotics group (p = 0.04). On multivariable analysis, blood loss ≥500 mL (OR, 5.1; 95% CI, 1.27-20.4; p = 0.02), ASA score ≥3 (OR, 3.9; 95% CI, 1.2-12.5; p = 0.01), contaminated types (OR, 3.6; 95% CI, 1.5-8.6; p = 0.01), and administration of preoperative oral antibiotics (OR, 0.20; 95% CI, 0.06-0.60; p = 0.005) independently affected the incidence of surgical site infections. LIMITATIONS: This was a single-center study.
CONCLUSION: Preoperative oral antibiotics, as adjunct therapy to systemic antibiotics and mechanical bowel preparation, significantly reduced surgical site infections and minimized the readmission rates in clean contaminated, contaminated, and dirty types of colorectal surgery. See Video Abstract at http://links.lww.com/DCR/A437.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29112565     DOI: 10.1097/DCR.0000000000000927

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  SSAT State-of-the-Art Conference: Advancements in the Microbiome.

Authors:  Miquell O Miller; Purna C Kashyap; Sarah L Becker; Ryan M Thomas; Richard A Hodin; George Miller; Mautin Hundeyin; Smruti Pushalkar; Deirdre Cohen; Deepak Saxena; Benjamin D Shogan; Gareth J Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2021-07       Impact factor: 3.452

2.  Surgical Revision Promotes Presence of Enterococcus spp. in Abdominal Superficial Surgical Site Infections.

Authors:  Matthias Mehdorn; Woubet Tefera Kassahun; Norman Lippmann; Uwe Scheuermann; Linda Groos; Dorina Buchloh; Boris Jansen-Winkeln; Ines Gockel
Journal:  J Gastrointest Surg       Date:  2021-10-18       Impact factor: 3.452

3.  Topical antimicrobial prophylaxis in colorectal surgery for the prevention of surgical wound infection: a systematic review and meta-analysis.

Authors:  R L Nelson; N M Iqbal; A Kravets; R Khateeb; M Raza; M Siddiqui; I Taha; A Tummala; R Epple; S Huang; M Wen
Journal:  Tech Coloproctol       Date:  2018-07-17       Impact factor: 3.781

Review 4.  Minimally Invasive Management of Diverticular Disease.

Authors:  Andrea Madiedo; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2021-02-24

5.  Perioperative use of cefazolin ameliorates postoperative cognitive dysfunction but induces gut inflammation in mice.

Authors:  Peng Liang; Weiran Shan; Zhiyi Zuo
Journal:  J Neuroinflammation       Date:  2018-08-22       Impact factor: 8.322

6.  Current practice patterns of preoperative bowel preparation in colorectal surgery: a nation-wide survey by the Chinese Society of Colorectal Cancer.

Authors:  Zheng Liu; Ming Yang; Zhi-Xun Zhao; Xu Guan; Zheng Jiang; Hai-Peng Chen; Song Wang; Ji-Chuan Quan; Run-Kun Yang; Xi-Shan Wang
Journal:  World J Surg Oncol       Date:  2018-07-09       Impact factor: 2.754

7.  The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis.

Authors:  Katie E Rollins; Hannah Javanmard-Emamghissi; Austin G Acheson; Dileep N Lobo
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

8.  Incidence and risk factors of surgical site infection following colorectal surgery in China: a national cross-sectional study.

Authors:  Xufei Zhang; Zhiwei Wang; Jun Chen; Peige Wang; Suming Luo; Xinjian Xu; Wei Mai; Guangyi Li; Gefei Wang; Xiuwen Wu; Jianan Ren
Journal:  BMC Infect Dis       Date:  2020-11-12       Impact factor: 3.090

9.  Mechanical and oral antibiotic bowel preparation versus no bowel preparation in right and left colectomy: subgroup analysis of MOBILE trial.

Authors:  L Koskenvuo; T Lehtonen; S Koskensalo; S Rasilainen; K Klintrup; A Ehrlich; T Pinta; T Scheinin; V Sallinen
Journal:  BJS Open       Date:  2021-03-05

10.  Mechanical plus oral bowel preparation with paromomycin and metronidazole reduces infectious complications in elective colorectal surgery: a matched case-control study.

Authors:  Matthias Mehdorn; Christoph Lübbert; Iris F Chaberny; Ines Gockel; Boris Jansen-Winkeln
Journal:  Int J Colorectal Dis       Date:  2021-04-25       Impact factor: 2.571

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.